<code id='19761CA9AB'></code><style id='19761CA9AB'></style>
    • <acronym id='19761CA9AB'></acronym>
      <center id='19761CA9AB'><center id='19761CA9AB'><tfoot id='19761CA9AB'></tfoot></center><abbr id='19761CA9AB'><dir id='19761CA9AB'><tfoot id='19761CA9AB'></tfoot><noframes id='19761CA9AB'>

    • <optgroup id='19761CA9AB'><strike id='19761CA9AB'><sup id='19761CA9AB'></sup></strike><code id='19761CA9AB'></code></optgroup>
        1. <b id='19761CA9AB'><label id='19761CA9AB'><select id='19761CA9AB'><dt id='19761CA9AB'><span id='19761CA9AB'></span></dt></select></label></b><u id='19761CA9AB'></u>
          <i id='19761CA9AB'><strike id='19761CA9AB'><tt id='19761CA9AB'><pre id='19761CA9AB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:375
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          NEJM study link tiny plastics in blood vessels to heart problems
          NEJM study link tiny plastics in blood vessels to heart problems

          DESIREEMARTIN/AFPviaGettyImagesMicroandnanoplastics,tinypiecesofplasticscatteredthroughouttheenviron

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Amylyx ALS drug fails large clinical trial

          JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST